Peter C. Enzinger

24.8k citations
147 papers · 8.4k · 3 hit papers · h-index 39

Impact in

Papers in

    • Gastric Cancer Management and Outcomes 74
    • Lung Cancer Treatments and Mutations 28
    • Colorectal Cancer Treatments and Studies 36
    • Pancreatic and Hepatic Oncology Research 25
    • Cancer Immunotherapy and Biomarkers 21
    • Cancer Treatment and Pharmacology 11

Peter C. Enzinger

140 papers receiving 8.3k citations

Peter C. Enzinger's Hit Papers

Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial 2023 · 342 citations
3420+7+15Years since publication50010001.5k2.0k

Peers

Peter C. Enzinger
Comparison fields: 5 of 122
  • Oncology 4.2k
  • Pulmonary and Respiratory Medicine 3.5k
  • Gastroenterology 537
  • Surgery 3.4k
  • Cancer Research 1.1k
Replace Maria Di Bartolomeo with:
Maria Di Bartolomeo Italy
Rosine Guimbaud France
Tarek Sahmoud Belgium
Jörg T. Hartmann Germany
Young Suk Park South Korea
Mark M. Zalupski United States
Catherine Delbaldo France
Emmanuel Mitry France
Mark S. Talamonti United States
Jianming Xu China
Peter C. Enzinger relative to Maria Di Bartolomeo Italy Maria Di Bartolomeo's profile →
Citations per field
00.5×1.5×2.3×
Maria Di Bartolomeo · 1×
Citations per year

Countries citing papers authored by Peter C. Enzinger

Since Specialization
Citations

This map shows the geographic impact of Peter C. Enzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Enzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Enzinger more than expected).

Fields of papers citing papers by Peter C. Enzinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Enzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Enzinger. The network helps show where Peter C. Enzinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter C. Enzinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter C. Enzinger Line = papers co-authored together Peter C. Enzinger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Esophageal Cancer
Hit paper breakdown →
20032117
2 2006379
3
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus
Hit paper breakdown →
2018362
4
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
Hit paper breakdown →
2023342
5 2006302
6 2014289
7 2008286
8 2008249
9 2009229
10 2012207
11 1999200
12 2007190
13 2019157
14 2006140
15 2019125
16 2007124
17 2005123
18 2014120
19
Chemotherapy in esophageal cancer.
1999113
20 202098

About Peter C. Enzinger

Peter C. Enzinger is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Epidemiology, having authored 147 papers that have together received 8.4k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (74 papers), Esophageal Cancer Research and Treatment (48 papers), Colorectal Cancer Treatments and Studies (36 papers), Lung Cancer Treatments and Mutations (28 papers), Pancreatic and Hepatic Oncology Research (25 papers), Cancer Immunotherapy and Biomarkers (21 papers), Neuroendocrine Tumor Research Advances (13 papers) and Cancer Treatment and Pharmacology (11 papers). The work is most often cited by research in Oncology (4.2k citations), Pulmonary and Respiratory Medicine (3.5k citations), Gastroenterology (537 citations), Surgery (3.4k citations) and Cancer Research (1.1k citations). Peter C. Enzinger has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Robert J. Mayer, Charles S. Fuchs, Jeffrey W. Clark, David P. Ryan, Jeffrey A. Meyerhardt, Matthew H. Kulke, Keith Stuart, Lawrence S. Blaszkowsky, Andrew X. Zhu and Alona Muzikansky. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Oncologist, Cancer and Future Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact